KR960703621A - 경피흡수 제제(Percutaneously absorbable preparation) - Google Patents

경피흡수 제제(Percutaneously absorbable preparation) Download PDF

Info

Publication number
KR960703621A
KR960703621A KR1019960700603A KR19960700603A KR960703621A KR 960703621 A KR960703621 A KR 960703621A KR 1019960700603 A KR1019960700603 A KR 1019960700603A KR 19960700603 A KR19960700603 A KR 19960700603A KR 960703621 A KR960703621 A KR 960703621A
Authority
KR
South Korea
Prior art keywords
fatty acid
monoglyceride
absorbable preparation
percutaneously absorbable
transdermal absorption
Prior art date
Application number
KR1019960700603A
Other languages
English (en)
Inventor
소토오 아사쿠라
수미히사 키무라
가추타케 카도
요시코 오히시
다케히사 하타
Original Assignee
후지야마 아키라
후지사와 야꾸힝 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후지야마 아키라, 후지사와 야꾸힝 고교 가부시키가이샤 filed Critical 후지야마 아키라
Publication of KR960703621A publication Critical patent/KR960703621A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 약물, 및 경피흡수 촉진제로서 모노글리세라이드 및 지방산을 함유함을 특징으로 하는 경피흡수제제에 관한 것이다.

Description

경피흡수 제제(Percutaneously absorbable preparation)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 약물, 및 경피흡수 촉진제로서 모노글리세라이드 및 지방산을 함유함을 특징으로 하는 경피흡수 제제.
  2. 제1항에 있어서, 모노글리세라이드가 중쇄 또는 장쇄 지방산 글리세린 모노에스테르이고, 지방산이 중쇄 또는 장쇄 지방산인 제제.
  3. 제1항 또는 2항에 있어서, 약물이 하기 구조식을 갖는 화합물인 제제.
  4. 제2항 또는 3항에 있어서, 모노글리세라이드가 모노카프린, 모노라우린 또는 모노올레인이고, 지방산이 스테아르산인 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019960700603A 1993-08-10 1994-08-04 경피흡수 제제(Percutaneously absorbable preparation) KR960703621A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP198014/1993 1993-08-10
JP19801493 1993-08-10
JP31631993 1993-12-16
JP316319/1993 1993-12-16
PCT/JP1994/001282 WO1995004551A1 (fr) 1993-08-10 1994-08-04 Preparation absorbable par voie percutanee

Publications (1)

Publication Number Publication Date
KR960703621A true KR960703621A (ko) 1996-08-31

Family

ID=26510724

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960700603A KR960703621A (ko) 1993-08-10 1994-08-04 경피흡수 제제(Percutaneously absorbable preparation)

Country Status (6)

Country Link
US (1) US5747069A (ko)
EP (1) EP0719561A4 (ko)
KR (1) KR960703621A (ko)
CN (1) CN1128955A (ko)
CA (1) CA2169172A1 (ko)
WO (1) WO1995004551A1 (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099067A1 (en) * 1993-07-08 2002-07-25 Ulrich Posanski Pharmaceutical compositions for sparingly soluble therapeutic agents
GB2327611B (en) * 1994-10-26 1999-06-02 Novartis Ag Macrolide compositions
WO1996033722A1 (fr) * 1995-04-27 1996-10-31 Kanebo, Ltd. Preparation externe contenant de l'emedastine
US6284226B1 (en) * 1997-03-14 2001-09-04 Fujisawa Pharmaceutical Co., Ltd. Aerosol composition containing middle-chain fatty acid triglyceride dispersant
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ATE485821T1 (de) * 2002-05-28 2010-11-15 Nycomed Gmbh Ophthalmologische zubereitung enthaltend roflumilast in der behandlung von krankheiten der augen
US20050053593A1 (en) * 2003-09-09 2005-03-10 3M Innovative Properties Company Antimicrobial compositions and methods
JP2007504826A (ja) * 2003-09-09 2007-03-08 スリーエム イノベイティブ プロパティズ カンパニー 濃厚な抗菌性組成物および方法
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
US10918618B2 (en) * 2005-03-10 2021-02-16 3M Innovative Properties Company Methods of reducing microbial contamination
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
TW200719884A (en) * 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
WO2006099232A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Antimicrobial pet wipes
TW200724134A (en) * 2005-03-10 2007-07-01 3M Innovative Properties Co Antimicrobial compositions and methods
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722941A (en) * 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
US4400295A (en) * 1979-03-24 1983-08-23 Loire Cosmetics Co., Ltd. Emulsifier composition
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
IL92537A (en) * 1988-12-15 1994-04-12 Riker Laboratories Inc Topical preparations and dermal systems containing 1-isobutyl-H1-imidazo [C-4,5] quinoline-4-amine
JPH0717498B2 (ja) * 1989-05-31 1995-03-01 興和株式会社 鎮咳去痰ソフトカプセル剤
GB8929070D0 (en) * 1989-12-22 1990-02-28 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
CN1128955A (zh) 1996-08-14
WO1995004551A1 (fr) 1995-02-16
US5747069A (en) 1998-05-05
EP0719561A4 (en) 1997-07-30
EP0719561A1 (en) 1996-07-03
CA2169172A1 (en) 1995-02-16

Similar Documents

Publication Publication Date Title
KR960703621A (ko) 경피흡수 제제(Percutaneously absorbable preparation)
KR840006280A (ko) α-시아노-3-페녹시-4-플루오로벤질 2'2-디메틸-3-(β'β-디클로로비닐)-시클로프로판 카복실레이트 함유 유인제의 제조방법
KR900700094A (ko) 지방산과 모노글리세라이드의 항비루스 및 항세균 활성
KR950031034A (ko) 화장품 또는 피부과용 조성물 및 그의 제법
CA2259297A1 (en) Parenteral paclitaxel in a stable non-toxic formulation
DE69112914D1 (de) Herstellungsverfahren von Mikrokugeln.
AR004483A1 (es) Compuestos para uso en terapia que comprenden un residuo de 1,3-propano diol como agente enlazante entre el residuo de ácido graso y un residuo bioactivo, usos de dichos compuestos y medicamentos , alimentos y formulaciones para el cuidado o tratamiento de la piel que comprenden a dichos compuestos
BR9810866A (pt) Composição farmacêutica em uma forma de formulação auto-emulsificante para compostos lipofìlicos
ATE96678T1 (de) Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen.
DE69508985D1 (de) Polyester Matrix für eine pharmazeutische Zusammensetzung mit verzögerter Freigabe
KR950031058A (ko) 경피 흡수 제제
RU94035673A (ru) Гелеобразная композиция для использования в области косметики и дерматологии
DK585889D0 (da) Farmaceutisk praeparat
KR910005841A (ko) 피부 미소순환에 작용하는 약리적 조성물
KR890001525A (ko) 지효성 경피 제제
KR910005876A (ko) 모세혈관 취약증의 치료를 위한 극소용 약학적 조성물
KR910007509A (ko) 친유성 약제용 주사 조성물
KR920009388A (ko) 니클로사미드를 함유하는 국소적용 침투방지 로션
EP1733741A3 (de) O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin
KR850000968A (ko) 피부 보호 조성물의 제조 방법
JPS5791913A (en) Pharmaceutical preparation of drug
KR890701098A (ko) 히드로퀴논 및 코지산을 함유하는 제약 또는 화장제 조성물
CA2027650A1 (en) Hair treatment composition
KR910009723A (ko) 4-카르바모일-1-β-D-리보푸라노실 이미다졸륨-5-올레이트 무수결정
ATE322896T1 (de) Verbesserte pharmazeutische zusammensetzung mit einem ppar-alpha-mittel und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application